- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- Fact Check
- Bone Health Fact Check
- Brain Health Fact Check
- Cancer Related Fact Check
- Child Care Fact Check
- Dental and oral health fact check
- Diabetes and metabolic health fact check
- Diet and Nutrition Fact Check
- Eye and ENT Care Fact Check
- Fitness fact check
- Gut health fact check
- Heart health fact check
- Kidney health fact check
- Medical education fact check
- Men's health fact check
- Respiratory fact check
- Skin and hair care fact check
- Vaccine and Immunization fact check
- Women's health fact check
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
Alleged irregularities in Covaxin deal: Brazil top prosecutor to investigate Bolsonaro
New Delhi: Brazil's top prosecutor agreed on Friday to request an investigation of President Jair Bolsonaro for dereliction of duty in the process of procuring an Indian COVID-19 vaccine, according to a copy of the request seen by Reuters.
The president has been caught up in allegations of irregularities surrounding the 1.6 billion reais ($316 million) contract signed in February for 20 million doses with a Brazilian intermediary for the vaccine's maker, Bharat Biotech. The government suspended the contract on Tuesday after a Senate commission raised suspicions of overpricing and corruption.
Federal prosecutors and the comptroller general's office, or CGU, are also investigating the alleged irregularities in a deal that has caused public outrage in Brazil, home to the world's second highest number of COVID-19 deaths.
The scandal involving Bharat's Covaxin vaccine has become a political nightmare for Bolsonaro in part because it allegedly involves the government's chief whip in the lower house of Congress, Ricardo Barros.
The investigation of the president by the top prosecutor's office, or PGR, has to be formally authorized by the Supreme Court, whose Justice Rosa Weber this week ordered it to take place immediately.
Prosecutor General Augusto Aras, who was appointed to the job by Bolsonaro, had wanted to delay an investigation until the Senate inquiry was over, but Justice Weber declined his request.
Bolsonaro's office did not immediately respond to a request for comment on the investigation sought by Aras.
Three opposition senators on the commission, including deputy chair Senator Randolfe Rodrigues, asked on Monday for the investigation of alleged corruption in the Covaxin deal.
The senators argued that Bolsonaro failed to take action when he was informed in March by a Health Ministry official Luis Ricardo Miranda and his brother, Congressman Luis Miranda, about alleged irregularities in the Covaxin negotiations.
The government denies any wrongdoing and has said Bolsonaro passed the Covaxin case to then minister of health, General Eduardo Pazuello, who found nothing irregular.
Dereliction of duty is a criminal offense in Brazil.
Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751
Next Story